Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

Gennao Bio Strengthens Board of Directors with Appointments of Peter Thompson, M.D., and Bradley Campbell Mar 17, 2022 07:30AM

Form SC 13D/A Adaptimmune Therapeutics Filed by: ORBIMED ADVISORS LLC Oct 10, 2018 02:38PM

Form 4 Adaptimmune Therapeutics For: Jun 04 Filed by: ORBIMED ADVISORS LLC Jun 6, 2018 06:11PM

Form 4 Adaptimmune Therapeutics For: May 30 Filed by: ORBIMED ADVISORS LLC Jun 1, 2018 05:26PM

Form 4 Adaptimmune Therapeutics For: May 14 Filed by: ORBIMED ADVISORS LLC May 16, 2018 05:23PM

Mar 29, 2018 06:55PM Form 4 ORBIMED ADVISORS LLC For: Mar 27 Filed by: Adaptimmune Therapeutics PLC
Mar 29, 2018 05:25PM Form SC 13D/A Adaptimmune Therapeutics Filed by: ORBIMED ADVISORS LLC
Jan 26, 2018 02:37PM Form SC 13D/A Adaptimmune Therapeutics Filed by: ORBIMED ADVISORS LLC
Mar 28, 2017 06:49PM Form 4 Adaptimmune Therapeutics For: Mar 27 Filed by: ORBIMED ADVISORS LLC
Nov 19, 2015 06:01AM Form SC 13D/A Adaptimmune Therapeutics Filed by: ORBIMED ADVISORS LLC
May 15, 2015 02:41PM Form SC 13D Adaptimmune Therapeutics Filed by: ORBIMED ADVISORS LLC

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed